MarketScreener Editorial Features North China Pharmaceutical Company.Ltd
Equities
600812
CNE000000D16
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.65 CNY | -2.92% | -6.25% | -18.42% |
Jun. 03 | China Grants Marketing Approval for Ampicillin Sodium as Active Pharmaceutical Ingredient | MT |
May. 24 | North China Pharmaceutical's Unit Passes GMP Inspection | MT |
- Stock Market
- Equities
- 600812 Stock
- News North China Pharmaceutical Company.Ltd
- MarketScreener Editorial Features